Log In
BCIQ
Print this Print this
 

Neurokinin 1 (NK1) Substance P receptor (TACR1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Neurokinin 1 (NK1) Substance P receptor (TACR1)

BCIQ
Print ChartPrint this
0 1 0 0 0 0 0 0 2 0 0 0 1 0 0 1 2 3 0 0 3 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationMarketed
Dermatology

0

0

3

0

0

0

Gastrointestinal

1

0

0

1

2

3

Neurology

0

0

2

0

0

0

Pulmonary

0

1

0

0

0

0




 Products Targeting Neurokinin 1 (NK1) Substance P receptor (TACR1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$100.0M

$7.0M

$214.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today